A-m Masson-Mes

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Analysis of active surveillance uptake for localized prostate cancer in Quebec in 2016: A Canadian bicentric study and comparison with 2010 data.

Analysis of active surveillance uptake for localized prostate cancer in Quebec in 2016: A Canadian bicentric study and comparison with 2010 data.

Journal: The French journal of urology
Published: August 04, 2023

Multi-size spheroid formation using microfluidic funnels.

Multi-size spheroid formation using microfluidic funnels.

Journal: Lab on a chip
Published: December 07, 2017

Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.

Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.

Journal: Oncogene
Published: August 05, 2016

The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.

The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.

Journal: Oncogene
Published: March 31, 2016

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.

Journal: British journal of cancer
Published: December 24, 2015

Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy.

Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy.

Journal: Lab on a chip
Published: December 15, 2015

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.

Journal: British journal of cancer
Published: January 23, 2015

Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity.

Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity.

Journal: Oncogenesis
Published: January 01, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026